Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis

计划入组 200 人 · 首次发布于 2014 年 12 月 4 日

Cholera Anti-Secretory Treatment Trial

计划入组 47 人 · 首次发布于 2019 年 11 月 4 日

IgA Nephropathy, Lymphocyte Homing and IgA Class Switch

计划入组 72 人 · 首次发布于 2013 年 1 月 25 日

sIgA immunotherapy (Secretory IgA)

ImmTOR + IgA protease (autoimmune dusease/IgA nephropathy)

IgA proteases(IGAN Biosciences)

Calliditas Therapeutics

Sweden

Fox Ira

Israel

INA RESPOND

Indonesia

Kenox and Lactiga Partner to Develop First-in-Class Mucosal Immunotherapy for Immunodeficient Patients

First Successful CAR T-Cell Therapy for Multidrug-Resistant Ulcerative Colitis Achieves Complete Remission

Multi-Component Intranasal COVID-19 Vaccine Shows Promise in Preclinical and Early Human Studies